Clinical Characteristics and Outcomes of Primary Immunodeficiencies in Thai Children: An 18-year Experience from a Tertiary Care Center

Benjasupattananan, P.; Simasathein, T.; Vichyanond, P.; Leungwedchakarn, V.; Visitsunthorn, Nualanong; Pacharn, Punchama; Jirapongsananuruk, Orathai

doi:10.1007/s10875-008-9273-5

Cited by 22 publications

(22 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Madkaikar et al reported 159 PID cases from a tertiary care center in India in 2013 followed by a more recent report describing 778 registered patients. Frequencies of PIDs were as follows: diseases of immune dysregulation (23.1%), phagocytic defects (21.3%) and predominant antibody deficiency Other registries were reported from Oman (140 patients with high proportion of patients with congenital defects of phagocyte 35%) [44], Taiwan (215 patients with 50.6% molecular diagnosis) [13], Malaysia (150 patients) [43,45], Thailand (67 patients) [46], Jordan (53 patients) [47], Singapore (39 patients) [48], UAE (30 patients) [49] and Bangladesh (13 patients) [50].…”

Section: Article Highlightsmentioning

confidence: 99%

Global systematic review of primary immunodeficiency registries

Abolhassani

Azizi

Sharifi

et al. 2020

Expert Review of Clinical Immunology

View full text Add to dashboard Cite

Introduction: During the last 4 decades, registration of patients with primary immunodeficiencies (PID) has played an essential role in different aspects of these diseases worldwide including epidemiological indexes, policymaking, quality controls of care/life, facilitation of genetic studies and clinical trials as well as improving our understanding about the natural history of the disease and the immune system function. However, due to the limitation of sustainable resources supporting these registries, inconsistency in diagnostic criteria and lack of molecular diagnosis as well as difficulties in the documentation and designing any universal platform, the global perspective of these diseases remains unclear. Areas covered: Published and unpublished studies from January 1981 to June 2020 were systematically reviewed on PubMed, Web of Science and Scopus. Additionally, the reference list of all studies was hand-searched for additional studies. This effort identified a total of 104614 registered patients and suggests identification of at least 10590 additional PID patients, mainly from countries located in Asia and Africa. Molecular defects in genes known to cause PID were identified and reported in 13852 (13.2% of all registered) patients. Expert opinion: Although these data suggest some progress in the identification and documentation of PID patients worldwide, achieving the basic requirement for the global PID burden estimation and registration of undiagnosed patients will require more reinforcement of the progress, involving both improved diagnostic facilities and neonatal screening.

show abstract

Section: Article Highlightsmentioning

confidence: 99%

Global systematic review of primary immunodeficiency registries

Abolhassani

Azizi

Sharifi

et al. 2020

Expert Review of Clinical Immunology

View full text Add to dashboard Cite

show abstract

“…All countries that participated in the first publication in 1998 reported an increase of PID cases, ranging between 10% and 80%. 24 These two reports highlight that, predominantly, antibody deficiencies remain the main PIDs registered in Latin America, with similar trends in other countries such as Australia, 37,38 China, 39,40 Egypt, 41 France, 42 Hong Kong, 43 Iran, [44][45][46] Italy, 47 Kuwait, 48 the Netherlands, 49 Norway, 50 Poland, 51 Republic of Ireland, 52 Spain, 53,54 Switzerland, 55 Taiwan, 56 Thailand, 57 Tunisia, 58 and the United States. 59,60 However, other well-defined PID syndromes, such as ataxia-telangiectasia, have been reported more frequently, especially in Mexico and Central America.…”

Section: Lasid Activitiesmentioning

confidence: 72%

Advances in primary immunodeficiency diseases in Latin America: epidemiology, research, and perspectives

Errante

Franco

Espinosa-Rosales³

et al. 2012

Annals of the New York Academy of Sciences

View full text Add to dashboard Cite

Primary immunodeficiencies (PIDs) are genetic disorders of the immune system comprising many different phenotypes. Although previously considered rare, recent advances in their clinical, epidemiological, and molecular definitions are revealing how much we still need to learn about them. For example, geographical and ethnic variations as well as the impact of certain practices influence their frequency and presentation, making it necessary to consider their study in terms of regions. The Latin American Society for Immunodeficiencies was established as an organization dedicated to provide scientific support for basic and clinical research and to develop tools and educational resources to promote awareness in the medical community. Initiatives such as these are positively influencing the way PIDs are tackled in these countries, as shown by recent reports and publications. This paper provides a historical compilation and a current view of the many issues faced by scientists studying these diseases in these countries, highlighting the diverse scientific contributions and offering a promising perspective for the further developments in this field in Latin America.

show abstract

“…Brazil reported 50 cases of deficiency complement, followed by 13 reports of Argentina (Leiva et al, 2007). Like others studies, predominantly antibody deficiency was the principal PID observed in Latin America, Australia (Baumgart et al, 1997;Kirkpatrick et al, 2007), China (Zhao et al, 2006;Wang et al, 2011), Egypt (Reda et al, 2009), French (CEREDIH, 2010, Hong Kong (Lam et al, 2005), Iran (Aghamohammadi et al, 2002;Farhoudi et al, 2005;Rezaei et al, 2006), Italy (Luzi et al, 1983), Kuwait (AlHerz, 2008), Netherland (Zegers et al, 1994), Norway (Stray-Pedersen et al, 2000), Poland (Bernatowska et al, 1998), Republic of Ireland (Abuzakouk et al, 2005), Spain (Matamoros et al, 1997;Milá et al, 2001), Swiss (Ryser et al, 1998), Taiwan (Lee et al, 2011), Thailand (Benjasupattananan et al, 2009), Tunisia (Bejaoui et al, 1997) and USA (Javier et al, 2000;Stiehm, 2007), Studies in other countries reveled major number of granulocyte dysfunction in India (Verma et al, 2008), and Combined T-and B-cell Immunodeficiency in Turk (Shabestari et al, 2007).…”

Section: Latin American Group Of Immunodeficiencymentioning

confidence: 99%

Primary Immunodeficiency Diseases in Latin America: Epidemiology and Perspectives

Errante¹,

Condino‐Neto²

2012

Epidemiology Insights

View full text Add to dashboard Cite

Clinical Characteristics and Outcomes of Primary Immunodeficiencies in Thai Children: An 18-year Experience from a Tertiary Care Center

Abstract: These results provide clinical features of PID in Thailand. Knowing these features will lead to prompt diagnosis and appropriate management.

Cited by 22 publications

References 45 publications

Global systematic review of primary immunodeficiency registries

Global systematic review of primary immunodeficiency registries

Advances in primary immunodeficiency diseases in Latin America: epidemiology, research, and perspectives

Primary Immunodeficiency Diseases in Latin America: Epidemiology and Perspectives

Contact Info

Product

Resources

About